Top Buy
Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 51 | 0 | 4 | 0 | €724.50 | €766.92 | 5.855% |
Gilead Sciences Inc | 12 | 1 | 3 | 0 | €61.30 | €86.77 | 41.551% |
Biogen Inc. | 44 | 2 | 3 | 1 | €201.10 | €293.57 | 45.983% |
AbbVie Inc. | 20 | 1 | 2 | 0 | €152.00 | €174.43 | 14.759% |
Zoetis Inc. A | 21 | 1 | 1 | 0 | €150.20 | €200.06 | 33.194% |
Regeneron Pharmaceuticals Inc. | 34 | 1 | 1 | 0 | €847.80 | €957.22 | 12.906% |
Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.80 | €124.93 | 3.418% |
Perrigo Co. plc | 3 | 0 | 0 | 0 | €30.77 | €35.99 | 16.949% |
Viatris Inc. | 1 | 0 | 0 | 0 | €10.84 | - | - |
Abbott Laboratories | 16 | 0 | 0 | 0 | €100.36 | €116.81 | 16.389% |
Amgen Inc. | 21 | 0 | 0 | 0 | €259.15 | €294.28 | 13.557% |
Vertex Pharmaceuticals Inc. | 40 | 2 | 0 | 0 | €377.05 | €382.71 | 1.500% |